Literature DB >> 24076576

Comparative tissue distribution profiles of five major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue Decoction by UPLC-TQ/MS.

Xuqin Shi1, Yuping Tang, Huaxu Zhu, Weixia Li, Zhenhao Li, Wei Li, Jin-ao Duan.   

Abstract

Astragali Radix (AR) and Angelicae Sinensis Radix (ASR) were frequently combined and used in China as herbal pair called as Danggui Buxue Decoction (DBD) for treatment of blood deficiency syndrome, such as women's ailments. This study is to investigate the tissue distribution profiles of five major bio-active constituents (ferulic acid, caffeic acid, calycosin-7-O-β-glucoside, ononin and astragaloside IV) in DBD after oral administration of DBD in blood deficiency rats, and to compare the difference between normal and blood deficiency rats. The blood deficiency rats were induced by bleeding from orbit at the dosages of 5.0mLkg(-1) every day, and the experimental period was 12 days. At the finally day of experimental period, both normal and blood deficiency rats were orally administrated with DBD, and then the tissues samples were collected at different time points. Ferulic acid, caffeic acid, calycosin-7-O-β-glucoside, ononin and astragaloside IV in different tissues were detected simultaneously by UPLC-TQ/MS, and the histograms were drawn. The results showed that the overall trend was CLiver>CKidney>CHeart>CSpleen>CLung, CC-30min>CM-30min>CM-60min>CC-5min>CM-5min>CC-60min>CM-240min>CC-240min. The contents of the detected compounds in liver were more than that in other tissues no matter in normal or blood deficiency rats. Compared to normal rats, partial contents of the compounds in blood deficiency rats' tissues at different time points had significant difference (P<0.05). This study was the first report about tissue distribution investigation in blood deficiency animals which is conducted by bleeding. And the results demonstrated that the five DBD components in normal and blood deficiency rats had obvious differences in some organs and time points, suggesting that the blood flow and perfusion rate of the organ were altered in blood deficiency animals.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bleeding; Blood deficiency; Blood loss anemia; Danggui Buxue Decoction; Tissue distribution; UPLC-TQ/MS

Mesh:

Substances:

Year:  2013        PMID: 24076576     DOI: 10.1016/j.jpba.2013.08.043

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

1.  Metabonomics Study of the Hematopoietic Effect of Medicinal Wine Maoji Jiu on a Blood Deficiency Rat Model by Ultra-High-Performance Liquid Chromatography Coupled to Quadrupole Time-of-Flight Mass Spectrometry and a Pattern Recognition Approach.

Authors:  Fanqiang Zeng; Yongli Xu; Yilian Li; Zhigang Yan; Li Li
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

2.  Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.

Authors:  Xin Tian; Hong-Meng Li; Jing-Yao Wei; Bing-Jie Liu; Yu-Hai Zhang; Gao-Ju Wang; Jun-Biao Chang; Hai-Ling Qiao
Journal:  Front Pharmacol       Date:  2016-08-18       Impact factor: 5.810

3.  Chemical and bioactive comparison of Panax notoginseng root and rhizome in raw and steamed forms.

Authors:  Yin Xiong; Lijuan Chen; Jinhui Man; Yupiao Hu; Xiuming Cui
Journal:  J Ginseng Res       Date:  2017-11-21       Impact factor: 6.060

4.  Screening study of blood-supplementing active components in water decoction of Angelica sinensis processed with yellow rice wine based on response surface methodology.

Authors:  Peng Ji; Chenchen Li; Yanming Wei; Fanlin Wu; Shengli Liu; Yongli Hua; Wanling Yao; Xiaosong Zhang; Ziwen Yuan; Yanqiao Wen
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

5.  Comprehensive Metabolomics and Network Pharmacology to Explore the Mechanism of 5-Hydroxymethyl Furfural in the Treatment of Blood Deficiency Syndrome.

Authors:  Wensen Zhang; Na Cui; Fazhi Su; Yangyang Wang; Bingyou Yang; Yanping Sun; Wei Guan; Haixue Kuang; Qiuhong Wang
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

6.  Chinese herbal decoction astragalus and angelica exerts its therapeutic effect on renal interstitial fibrosis through the inhibition of MAPK, PI3K-Akt and TNF signaling pathways.

Authors:  Hao Yuan; Xuelian Wu; Xiaomin Wang; Chengfu Yuan
Journal:  Genes Dis       Date:  2020-06-21

7.  Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication.

Authors:  Gyeong-Seok Lee; Hee-Yeon Jeong; Hyeon-Gung Yang; Young-Ran Seo; Eui-Gil Jung; Yong-Seok Lee; Kung-Woo Nam; Wan-Jong Kim
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

8.  Comparative Pharmacokinetics of three major bioactive components in rats after oral administration of Typhae Pollen-Trogopterus Feces drug pair before and after compatibility.

Authors:  Huiting Zeng; Ping Xue; Shulan Su; Xiaochen Huang; Erxin Shang; Jianming Guo; Dawei Qian; Yuping Tang; Jin-ao Duan
Journal:  Daru       Date:  2016-01-20       Impact factor: 3.117

9.  Integrated Metabolomics and Network Pharmacology Approach to Explain Possible Action Mechanisms of Xin-Sheng-Hua Granule for Treating Anemia.

Authors:  Han-Qing Pang; Shi-Jun Yue; Yu-Ping Tang; Yan-Yan Chen; Ya-Jie Tan; Yu-Jie Cao; Xu-Qin Shi; Gui-Sheng Zhou; An Kang; Sheng-Liang Huang; Ya-Jun Shi; Jing Sun; Zhi-Shu Tang; Jin-Ao Duan
Journal:  Front Pharmacol       Date:  2018-03-02       Impact factor: 5.810

10.  Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus-Angelica Combination.

Authors:  Huifang Yan; Xiwei Peng; Hao Xu; Jiahuan Zhu; Changqing Deng
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.